X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (9) 9
cancer (5) 5
index medicus (5) 5
article (4) 4
dendritic cells (4) 4
immunotherapy (4) 4
ovarian cancer (4) 4
animals (3) 3
anti-pd-1 antibody (3) 3
care and treatment (3) 3
dendritic cells - immunology (3) 3
ductal adenocarcinoma (3) 3
female (3) 3
health aspects (3) 3
humans (3) 3
macrophages (3) 3
microenvironment (3) 3
myeloid cells (3) 3
regulatory t-cells (3) 3
tumor microenvironment (3) 3
antitumor immunity (2) 2
biomedicine (2) 2
cancer research (2) 2
cancer vaccines - immunology (2) 2
chemical and pharmacologic phenomena (2) 2
chromosomes (2) 2
development and progression (2) 2
immunity (2) 2
immunology (2) 2
in-vivo (2) 2
mice (2) 2
ovarian neoplasms - immunology (2) 2
ovarian-cancer (2) 2
pd-1 (2) 2
programmed cell death 1 receptor - immunology (2) 2
single nucleotide polymorphisms (2) 2
t cells (2) 2
tumor microenvironment - immunology (2) 2
316l ss (1) 1
abridged index medicus (1) 1
activation (1) 1
adaptive immunity (1) 1
alpha (1) 1
amphiregulin (1) 1
anti-interleukin-6 monoclonal-antibody (1) 1
antibodies - immunology (1) 1
antibodies - pharmacology (1) 1
antibodies, monoclonal - immunology (1) 1
antibodies, monoclonal - therapeutic use (1) 1
anticancer properties (1) 1
antigen presentation (1) 1
antigens, neoplasm - immunology (1) 1
antitumor activity (1) 1
apoptosis (1) 1
aryl-hydrocarbon receptor (1) 1
ascites (1) 1
b7 family (1) 1
b7-h1 antigen - immunology (1) 1
b7-h1 expression (1) 1
bacterial delivery (1) 1
biomarkers (1) 1
biomaterial (1) 1
biomedicine general (1) 1
biomedicine, general (1) 1
blockade (1) 1
blocking antibodies (1) 1
bone marrow (1) 1
breast cancer (1) 1
cancer stem-cells (1) 1
cancer vaccines - pharmacology (1) 1
cancer vaccines - therapeutic use (1) 1
carcinoma (1) 1
cd8 t-cells (1) 1
cd8-positive t-lymphocytes - drug effects (1) 1
cd8-positive t-lymphocytes - immunology (1) 1
cell death (1) 1
cell line, tumor (1) 1
cell lung cancers (1) 1
checkpoint (1) 1
checkpoint inhibition (1) 1
chemotherapy (1) 1
colorectal-cancer (1) 1
combination therapy (1) 1
ctla-4 (1) 1
cytokines (1) 1
death ligand 1 (1) 1
dendritic cells - drug effects (1) 1
dendritic cells - metabolism (1) 1
dendritic cells - pathology (1) 1
disease-free survival (1) 1
dna-encoded monoclonal antibodies (1) 1
drug delivery systems (1) 1
egf receptor (1) 1
ellagic acid (1) 1
expression (1) 1
factor binding protein-2 (1) 1
fibroblasts (1) 1
folate-receptor-alpha (1) 1
gastric-cancer (1) 1
gefitinib (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer and Metastasis Reviews, ISSN 0167-7659, 9/2016, Volume 35, Issue 3, pp. 489 - 489
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s10555-016-9627-z 
Biomedicine, general | Cancer Research | Oncology | Biomedicine | Care and treatment | Molecular biology | Health aspects | Immunotherapy | Ovarian cancer | Cancer
Journal Article
Cancer and Metastasis Reviews, ISSN 0167-7659, 09/2016, Volume 35, Issue 3, p. 489
Journal Article
Cancer and Metastasis Reviews, ISSN 0167-7659, 03/2015, Volume 34, Issue 1, pp. 53 - 74
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s10555-014-9540-2 Clinical... 
Care and treatment | Dendritic cells | Immunotherapy | Development and progression | Single nucleotide polymorphisms | T cells | Macrophages | Chromosomes | Health aspects | Ovarian cancer | Cancer
Journal Article
Journal Article
Journal of immunology (Baltimore, Md. : 1950), ISSN 0022-1767, 4/2015, Volume 194, Issue 7, pp. 2985 - 2991
Dendritic cells (DCs) play a pivotal role in the tumor microenvironment (TME), the latter of which is known to affect disease progression in many human... 
Journal Article
01/2016, ISBN 9781369320022
While there is great potential immunotherapies have at best only resulted in modest increases in survival; with only a small fraction of patients being cured.... 
Immunology | Oncology
Dissertation
Cancer research, ISSN 0008-5472, 12/2017, Volume 77, Issue 23, pp. 6667 - 6678
Ligation of PD-1 in the tumor microenvironment is known to inhibit effective adaptive anti-tumor immunity. Blockade of PD-1 in humans has resulted in... 
checkpoint | tumor microenvironment
Journal Article
Cancer Research, ISSN 0008-5472, 11/2018, Volume 78, Issue 21, pp. 6235 - 6246
Major contributors to therapeutic resistance in pancreatic ductal adenocarcinoma (PDAC) include Kras mutations, a dense desmoplastic stroma that prevents drug... 
GROWTH-FACTOR RECEPTOR | AMPHIREGULIN | GEFITINIB | MICROENVIRONMENT | ONCOLOGY | CELL LUNG CANCERS | DUCTAL ADENOCARCINOMA | COLORECTAL-CANCER | MOUSE MODEL | KRAS | EGF RECEPTOR
Journal Article
Cancer Research, ISSN 0008-5472, 11/2018, Volume 78, Issue 21, pp. 6146 - 6158
Although smoking is a significant risk factor for pancreatic ductal adenocarcinoma (PDAC), the molecular mechanisms underlying PDAC development and progression... 
TUMOR PROGRESSION | NICOTINE | MICROENVIRONMENT | ONCOLOGY | DUCTAL ADENOCARCINOMA | MACROPHAGES | RECEPTOR | ALPHA | SMOKING | MYELOID CELLS | FIBROBLASTS
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2015, Volume 21, Issue 16 Supplement, pp. POSTER-THER-1418 - POSTER-THER-1418
Journal Article
Molecular cancer therapeutics, ISSN 1535-7163, 02/2019, Volume 18, Issue 2, pp. 301 - 311
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive malignancy and is highly resistant to standard treatment regimens. Targeted therapies against KRAS, a... 
METABOLITES | INHIBITION | T-CELL IMMUNITY | MICROENVIRONMENT | ONCOLOGY | DUCTAL ADENOCARCINOMA | KINASE | GROWTH | ELLAGIC ACID | MTOR | CHEMOTHERAPY
Journal Article
Materials Today: Proceedings, ISSN 2214-7853, 2019, Volume 15, pp. 336 - 343
Biomaterials had been comprehensively studied for many decades. The main focus was to coat a bioactive film on substrate that enhances its wear resistance,... 
PMEDM | Biomaterial | SEM | 316L SS | XRD | HAp powder
Journal Article
Journal Article
Journal Article
Medicines (Basel, Switzerland), ISSN 2305-6320, 10/2018, Volume 5, Issue 4, p. 114
Checkpoint inhibition (CPI) has been a rare success story in the field of cancer immunotherapy. Knowledge gleaned from preclinical studies and patients that do... 
nanoparticles | resistance to therapy | liposomes | checkpoint inhibition | biomarkers | radiation therapy | combination therapy | CTLA-4 | PD-1
Journal Article
Medicines, ISSN 2305-6320, 07/2019, Volume 6, Issue 3, p. 74
Checkpoint inhibition (CPI) therapies have been proven to be powerful clinical tools in treating cancers. FDA approvals and ongoing clinical development of... 
drug delivery systems | DNA-encoded monoclonal antibodies | nanobodies | platelets as delivery vehicles | immune-related adverse events | hydrogels | bacterial delivery | resistance to checkpoint blockade | hematopoietic stem cells | viral delivery of checkpoint inhibitors
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.